Literature DB >> 20691751

Cervical intraepithelial neoplasia: Telomerase activity and splice pattern of hTERT mRNA.

A A Petrenko1, L I Korolenkova, D A Skvortsov, M D Fedorova, M U Skoblov, A V Baranova, M E Zvereva, M P Rubtsova, F L Kisseljov.   

Abstract

Cervical cancers are characterized by the persistence of human papilloma virus (HPV) genome that is found in tissue samples starting from the early stages of tumor progression. Just like in other tumors, the activation of telomerase was observed in cervical carcinomas, but information about its expression was controversial. The aim of this study is to find possible correlations between the presence of HPV sequences, activity of telomerase and expression of different spliced forms of hTERT RNA in cervical intraepithelial neoplasias (CIN). The results show that HPV DNA is present in 60% of normal tissue adjacent to CIN lesions and up to 84% in CIN samples. Telomerase activity was found in 28% of adjacent normal tissue and in 68% of CIN II-III. hTERT RNA that encodes an active enzyme was present almost in all CIN samples. Variations in levels of telomerase activity are possibly not regulated by the splicing forms of hTERT mRNA with deletions.
Copyright © 2010. Published by Elsevier Masson SAS.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20691751     DOI: 10.1016/j.biochi.2010.07.015

Source DB:  PubMed          Journal:  Biochimie        ISSN: 0300-9084            Impact factor:   4.079


  2 in total

1.  Telomerase activity in peripheral blood mononuclear cells as a universal scale for quantitative measurement of telomerase activation on the example of liver diseases.

Authors:  D A Skvortsov; M A Ezhova; Y E Lourie; A V Metelin; I D Strazhesko; E N Dudinskaya; M A Kalinina; M E Zvereva; O A Dontsova; E F Kim
Journal:  Dokl Biochem Biophys       Date:  2015-07-12       Impact factor: 0.788

2.  MDS shows a higher expression of hTERT and alternative splice variants in unactivated T-cells.

Authors:  Wen Dong; Lei Wu; Houfang Sun; Xiubao Ren; Pearlie K Epling-Burnette; Lili Yang
Journal:  Oncotarget       Date:  2016-11-01
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.